Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study.

1. Twelves, C.J.
2. Butts, C.A.
3. Cassidy, J.
4. Conroy, T.
5. Braud, F.
6. Diaz-Rubio, E.
7. Tabernero, J.M.
8. Schoffski, P.
9. Figer, A.
10. Brunet, R.
11. Grossmann, J.
12. Sobrero, A.F.
13. Van Cutsem, E.J.